COVID-19 during Pregnancy and Postpartum.

Naidu Ms PharmD SAG, Clemens DrPH Fift Cfs Fasn Facn Cns Fiafst RA, Pressman Md Ms Facn P, Zaigham BSc Md PhD M, Kadkhoda PhD Sm Ascp D Abmm D Abmli K, Davies PhD DSc Mae Frsc Frcp Fls Fri KJA, Naidu PhD Facn Fls Fissvd AS

J Diet Suppl - (-) 1-28 [2020-11-08; online 2020-11-08]

Coronavirus Disease 2019 (COVID-19) triggered by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection has been declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Oxidative stress and its related metabolic syndromes are potential risk factors in the susceptibility to, and severity of COVID-19. In concert with the earliest reports of COVID-19, obstetricians started to diagnose and treat SARS-CoV-2 infections during pregnancy ("COVID-19-Pregnancy"). High metabolic demand to sustain normal fetal development increases the burden of oxidative stress in pregnancy. Intracellular redox changes intertwined with acute phase responses at the maternal-fetal interface could amplify during pregnancy. Interestingly, mother-to-fetus transmission of SARS-CoV-2 has not been detected in most of the COVID-19-Pregnancy cases. This relative absence of vertical transmission may be related to the presence of lactoferrin in the placenta, amniotic fluid, and lacteal secretions. However, the cytokine-storm induced during COVID-19-Pregnancy may cause severe inflammatory damage to the fetus, and if uncontrolled, may later result in autism spectrum-like disorders and brain development abnormalities in neonates. Considering this serious health threat to child growth and development, the prevention of COVID-19 during pregnancy should be considered a high priority. This review summarizes the intricate virulence factors of COVID-19 and elucidate its pathobiological spectrum during pregnancy and postpartum periods with a focus on the putative and complex roles of endogenous and exogenous lactoferrin in conferring immunological advantage to the host.

Type: Review

PubMed 33164601

DOI 10.1080/19390211.2020.1834049

Crossref 10.1080/19390211.2020.1834049

Publications 7.1.2